Global Aquaporin Supply, Demand and Key Producers, 2026-2032

June 2026 | 218 pages | ID: G79B3F7D4F60EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Aquaporin market size is expected to reach $ 111 million by 2032, rising at a market growth of 6.9% CAGR during the forecast period (2026-2032).

Aquaporin is a family of transmembrane water-channel proteins and related commercial research products that selectively facilitate rapid water transport across biological or biomimetic membranes along osmotic gradients. Native Aquaporin proteins are hydrophobic membrane proteins of about 30 kDa per monomer, typically containing multiple transmembrane helices that create a narrow pore, and many isoforms assemble as tetramers in which each monomer forms an independent water channel. In the commercial market, Aquaporin is not supplied as one single physical form; it is delivered as lyophilized or liquid antibodies, ELISA or chemiluminescent assay kits, recombinant proteins, antigen peptides, plasmids, cell models, small-molecule channel blockers, and limited biomimetic membrane components. Major product categories include Anti-Aquaporin Antibody, Aquaporin Channel Blocker, and other Aquaporin-related reagents. These products are used in life-science research, immunoassay development, disease-mechanism studies, drug screening, water-transport analysis, and biomimetic membrane material development.

The market opportunity for Aquaporin-related products is mainly driven by deeper life-science research, growing neuroimmunology studies, advances in membrane-protein structural biology, and rising demand for highly specific assays. Aquaporin-4 is closely linked to neuromyelitis optica spectrum disorders, brain edema, astrocyte biology, and cerebrospinal-fluid exchange, which supports continuous demand for antibodies, assay kits, recombinant antigens, cell models, and channel blockers. Improvements in cryo-EM, recombinant expression, monoclonal antibody generation, and automated immunoassay platforms also improve product validation and stability, supporting higher-value antibodies, quantitative kits, and novel modulators.

The main challenges are that this remains a niche market with high technical barriers and strong dependence on validation. Product performance varies significantly by isoform, species, tissue localization, and epitope design, and can be affected by immunogen selection, conformational integrity, batch consistency, and application-specific testing conditions. Channel blockers still face issues related to selectivity, in vivo translation, and complex pharmacology. Biomimetic membrane products have energy-saving and selectivity potential, but large-scale manufacturing, protein stability, membrane lifetime, customer qualification cycles, and funding continuity remain major constraints.

Downstream demand is expected to grow mainly through research and assay development. Universities, hospital research centers, and pharmaceutical companies will continue to purchase antibodies, recombinant proteins, and small-molecule tools for mechanism studies, target validation, and screening. Neuroimmunology, autoimmune disease, kidney disease, tumor microenvironment, and brain-water metabolism are likely to be the major sources of incremental demand. Industrial water treatment and drinking-water applications are more likely to progress through collaborative development, licensing, or small-batch high-end membrane modules rather than immediate large-scale replacement of conventional membranes.

This report studies the global Aquaporin demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Aquaporin, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Aquaporin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Aquaporin total market, 2021-2032, (USD Million)
Global Aquaporin total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Aquaporin total market, key domestic companies, and share, (USD Million)
Global Aquaporin revenue by player, revenue and market share 2021-2026, (USD Million)
Global Aquaporin total market by Type, CAGR, 2021-2032, (USD Million)
Global Aquaporin total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Aquaporin market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Danaher, Merck KGaA, Bio-Techne, Bio-Rad Laboratories, Cell Signaling Technology, Proteintech Group, Santa Cruz Biotechnology, Alomone Labs, Cayman Chemical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Aquaporin market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Aquaporin Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Aquaporin Market, Segmentation by Type:
  • Anti-Aquaporin Antibody
  • Aquaporin Channel Blocker
  • Others
Global Aquaporin Market, Segmentation by Target Isoform:
  • AQP1 Products
  • AQP2 Products
  • AQP3 Products
  • AQP4 Products
  • Others
Global Aquaporin Market, Segmentation by Physical State:
  • Solid Products
  • Liquid Products
Global Aquaporin Market, Segmentation by Application:
  • Medicine
  • Research
  • Purification Of Water
  • Others
Companies Profiled:
  • Thermo Fisher Scientific
  • Danaher
  • Merck KGaA
  • Bio-Techne
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • Proteintech Group
  • Santa Cruz Biotechnology
  • Alomone Labs
  • Cayman Chemical
  • MedChemExpress
  • TargetMol
  • Abbexa
  • GeneTex
  • Atlas Antibodies
  • StressMarq Biosciences
  • Biorbyt
  • NSJ Bioreagents
  • Aviva Systems Biology
  • MyBioSource
  • Assay Genie
  • RayBiotech
  • Bioss Antibodies
  • OriGene Technologies
  • Biomatik
  • RSR
  • Kronus
  • Medical & Biological Laboratories
  • ABclonal
  • Sino Biological
  • Elabscience Biotechnology
  • FineTest
  • HUABIO
  • CUSABIO
  • Cloud-Clone
  • Abnova
  • Boster Biological Technology
  • Affinity Biosciences
  • Signalway Antibody
  • ImmunoWay Biotechnology
Key Questions Answered
1. How big is the global Aquaporin market?
2. What is the demand of the global Aquaporin market?
3. What is the year over year growth of the global Aquaporin market?
4. What is the total value of the global Aquaporin market?
5. Who are the Major Players in the global Aquaporin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Aquaporin Introduction
1.2 World Aquaporin Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Aquaporin Total Market by Region (by Headquarter Location)
1.3.1 World Aquaporin Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Aquaporin Revenue (2021-2032)
1.3.3 China Based Company Aquaporin Revenue (2021-2032)
1.3.4 Europe Based Company Aquaporin Revenue (2021-2032)
1.3.5 Japan Based Company Aquaporin Revenue (2021-2032)
1.3.6 South Korea Based Company Aquaporin Revenue (2021-2032)
1.3.7 ASEAN Based Company Aquaporin Revenue (2021-2032)
1.3.8 India Based Company Aquaporin Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Aquaporin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Aquaporin Consumption Value (2021-2032)
2.2 World Aquaporin Consumption Value by Region
2.2.1 World Aquaporin Consumption Value by Region (2021-2026)
2.2.2 World Aquaporin Consumption Value Forecast by Region (2027-2032)
2.3 United States Aquaporin Consumption Value (2021-2032)
2.4 China Aquaporin Consumption Value (2021-2032)
2.5 Europe Aquaporin Consumption Value (2021-2032)
2.6 Japan Aquaporin Consumption Value (2021-2032)
2.7 South Korea Aquaporin Consumption Value (2021-2032)
2.8 ASEAN Aquaporin Consumption Value (2021-2032)
2.9 India Aquaporin Consumption Value (2021-2032)

3 WORLD AQUAPORIN COMPANIES COMPETITIVE ANALYSIS

3.1 World Aquaporin Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Aquaporin Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Aquaporin in 2025
3.2.3 Global Concentration Ratios (CR8) for Aquaporin in 2025
3.3 Aquaporin Company Evaluation Quadrant
3.4 Aquaporin Market: Overall Company Footprint Analysis
3.4.1 Aquaporin Market: Region Footprint
3.4.2 Aquaporin Market: Company Product Type Footprint
3.4.3 Aquaporin Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Aquaporin Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Aquaporin Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Aquaporin Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Aquaporin Consumption Value Comparison
4.2.1 United States VS China: Aquaporin Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Aquaporin Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Aquaporin Companies and Market Share, 2021-2026
4.3.1 United States Based Aquaporin Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Aquaporin Revenue, (2021-2026)
4.4 China Based Companies Aquaporin Revenue and Market Share, 2021-2026
4.4.1 China Based Aquaporin Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Aquaporin Revenue, (2021-2026)
4.5 Rest of World Based Aquaporin Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Aquaporin Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Aquaporin Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Aquaporin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Anti-Aquaporin Antibody
5.2.2 Aquaporin Channel Blocker
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Aquaporin Market Size by Type (2021-2026)
5.3.2 World Aquaporin Market Size by Type (2027-2032)
5.3.3 World Aquaporin Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY TARGET ISOFORM

6.1 World Aquaporin Market Size Overview by Target Isoform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Isoform
6.2.1 AQP1 Products
6.2.2 AQP2 Products
6.2.3 AQP3 Products
6.2.4 AQP4 Products
6.2.5 Others
6.3 Market Segment by Target Isoform
6.3.1 World Aquaporin Market Size by Target Isoform (2021-2026)
6.3.2 World Aquaporin Market Size by Target Isoform (2027-2032)
6.3.3 World Aquaporin Market Size Market Share by Target Isoform (2027-2032)

7 MARKET ANALYSIS BY PHYSICAL STATE

7.1 World Aquaporin Market Size Overview by Physical State: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Physical State
7.2.1 Solid Products
7.2.2 Liquid Products
7.3 Market Segment by Physical State
7.3.1 World Aquaporin Market Size by Physical State (2021-2026)
7.3.2 World Aquaporin Market Size by Physical State (2027-2032)
7.3.3 World Aquaporin Market Size Market Share by Physical State (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Aquaporin Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medicine
8.2.2 Research
8.2.3 Purification Of Water
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Aquaporin Market Size by Application (2021-2026)
8.3.2 World Aquaporin Market Size by Application (2027-2032)
8.3.3 World Aquaporin Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Aquaporin Product and Services
9.1.4 Thermo Fisher Scientific Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher Aquaporin Product and Services
9.2.4 Danaher Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Merck KGaA
9.3.1 Merck KGaA Details
9.3.2 Merck KGaA Major Business
9.3.3 Merck KGaA Aquaporin Product and Services
9.3.4 Merck KGaA Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck KGaA Recent Developments/Updates
9.3.6 Merck KGaA Competitive Strengths & Weaknesses
9.4 Bio-Techne
9.4.1 Bio-Techne Details
9.4.2 Bio-Techne Major Business
9.4.3 Bio-Techne Aquaporin Product and Services
9.4.4 Bio-Techne Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Techne Recent Developments/Updates
9.4.6 Bio-Techne Competitive Strengths & Weaknesses
9.5 Bio-Rad Laboratories
9.5.1 Bio-Rad Laboratories Details
9.5.2 Bio-Rad Laboratories Major Business
9.5.3 Bio-Rad Laboratories Aquaporin Product and Services
9.5.4 Bio-Rad Laboratories Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Bio-Rad Laboratories Recent Developments/Updates
9.5.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.6 Cell Signaling Technology
9.6.1 Cell Signaling Technology Details
9.6.2 Cell Signaling Technology Major Business
9.6.3 Cell Signaling Technology Aquaporin Product and Services
9.6.4 Cell Signaling Technology Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cell Signaling Technology Recent Developments/Updates
9.6.6 Cell Signaling Technology Competitive Strengths & Weaknesses
9.7 Proteintech Group
9.7.1 Proteintech Group Details
9.7.2 Proteintech Group Major Business
9.7.3 Proteintech Group Aquaporin Product and Services
9.7.4 Proteintech Group Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Proteintech Group Recent Developments/Updates
9.7.6 Proteintech Group Competitive Strengths & Weaknesses
9.8 Santa Cruz Biotechnology
9.8.1 Santa Cruz Biotechnology Details
9.8.2 Santa Cruz Biotechnology Major Business
9.8.3 Santa Cruz Biotechnology Aquaporin Product and Services
9.8.4 Santa Cruz Biotechnology Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Santa Cruz Biotechnology Recent Developments/Updates
9.8.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
9.9 Alomone Labs
9.9.1 Alomone Labs Details
9.9.2 Alomone Labs Major Business
9.9.3 Alomone Labs Aquaporin Product and Services
9.9.4 Alomone Labs Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Alomone Labs Recent Developments/Updates
9.9.6 Alomone Labs Competitive Strengths & Weaknesses
9.10 Cayman Chemical
9.10.1 Cayman Chemical Details
9.10.2 Cayman Chemical Major Business
9.10.3 Cayman Chemical Aquaporin Product and Services
9.10.4 Cayman Chemical Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Cayman Chemical Recent Developments/Updates
9.10.6 Cayman Chemical Competitive Strengths & Weaknesses
9.11 MedChemExpress
9.11.1 MedChemExpress Details
9.11.2 MedChemExpress Major Business
9.11.3 MedChemExpress Aquaporin Product and Services
9.11.4 MedChemExpress Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 MedChemExpress Recent Developments/Updates
9.11.6 MedChemExpress Competitive Strengths & Weaknesses
9.12 TargetMol
9.12.1 TargetMol Details
9.12.2 TargetMol Major Business
9.12.3 TargetMol Aquaporin Product and Services
9.12.4 TargetMol Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 TargetMol Recent Developments/Updates
9.12.6 TargetMol Competitive Strengths & Weaknesses
9.13 Abbexa
9.13.1 Abbexa Details
9.13.2 Abbexa Major Business
9.13.3 Abbexa Aquaporin Product and Services
9.13.4 Abbexa Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Abbexa Recent Developments/Updates
9.13.6 Abbexa Competitive Strengths & Weaknesses
9.14 GeneTex
9.14.1 GeneTex Details
9.14.2 GeneTex Major Business
9.14.3 GeneTex Aquaporin Product and Services
9.14.4 GeneTex Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 GeneTex Recent Developments/Updates
9.14.6 GeneTex Competitive Strengths & Weaknesses
9.15 Atlas Antibodies
9.15.1 Atlas Antibodies Details
9.15.2 Atlas Antibodies Major Business
9.15.3 Atlas Antibodies Aquaporin Product and Services
9.15.4 Atlas Antibodies Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Atlas Antibodies Recent Developments/Updates
9.15.6 Atlas Antibodies Competitive Strengths & Weaknesses
9.16 StressMarq Biosciences
9.16.1 StressMarq Biosciences Details
9.16.2 StressMarq Biosciences Major Business
9.16.3 StressMarq Biosciences Aquaporin Product and Services
9.16.4 StressMarq Biosciences Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 StressMarq Biosciences Recent Developments/Updates
9.16.6 StressMarq Biosciences Competitive Strengths & Weaknesses
9.17 Biorbyt
9.17.1 Biorbyt Details
9.17.2 Biorbyt Major Business
9.17.3 Biorbyt Aquaporin Product and Services
9.17.4 Biorbyt Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Biorbyt Recent Developments/Updates
9.17.6 Biorbyt Competitive Strengths & Weaknesses
9.18 NSJ Bioreagents
9.18.1 NSJ Bioreagents Details
9.18.2 NSJ Bioreagents Major Business
9.18.3 NSJ Bioreagents Aquaporin Product and Services
9.18.4 NSJ Bioreagents Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 NSJ Bioreagents Recent Developments/Updates
9.18.6 NSJ Bioreagents Competitive Strengths & Weaknesses
9.19 Aviva Systems Biology
9.19.1 Aviva Systems Biology Details
9.19.2 Aviva Systems Biology Major Business
9.19.3 Aviva Systems Biology Aquaporin Product and Services
9.19.4 Aviva Systems Biology Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Aviva Systems Biology Recent Developments/Updates
9.19.6 Aviva Systems Biology Competitive Strengths & Weaknesses
9.20 MyBioSource
9.20.1 MyBioSource Details
9.20.2 MyBioSource Major Business
9.20.3 MyBioSource Aquaporin Product and Services
9.20.4 MyBioSource Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 MyBioSource Recent Developments/Updates
9.20.6 MyBioSource Competitive Strengths & Weaknesses
9.21 Assay Genie
9.21.1 Assay Genie Details
9.21.2 Assay Genie Major Business
9.21.3 Assay Genie Aquaporin Product and Services
9.21.4 Assay Genie Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Assay Genie Recent Developments/Updates
9.21.6 Assay Genie Competitive Strengths & Weaknesses
9.22 RayBiotech
9.22.1 RayBiotech Details
9.22.2 RayBiotech Major Business
9.22.3 RayBiotech Aquaporin Product and Services
9.22.4 RayBiotech Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 RayBiotech Recent Developments/Updates
9.22.6 RayBiotech Competitive Strengths & Weaknesses
9.23 Bioss Antibodies
9.23.1 Bioss Antibodies Details
9.23.2 Bioss Antibodies Major Business
9.23.3 Bioss Antibodies Aquaporin Product and Services
9.23.4 Bioss Antibodies Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Bioss Antibodies Recent Developments/Updates
9.23.6 Bioss Antibodies Competitive Strengths & Weaknesses
9.24 OriGene Technologies
9.24.1 OriGene Technologies Details
9.24.2 OriGene Technologies Major Business
9.24.3 OriGene Technologies Aquaporin Product and Services
9.24.4 OriGene Technologies Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 OriGene Technologies Recent Developments/Updates
9.24.6 OriGene Technologies Competitive Strengths & Weaknesses
9.25 Biomatik
9.25.1 Biomatik Details
9.25.2 Biomatik Major Business
9.25.3 Biomatik Aquaporin Product and Services
9.25.4 Biomatik Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Biomatik Recent Developments/Updates
9.25.6 Biomatik Competitive Strengths & Weaknesses
9.26 RSR
9.26.1 RSR Details
9.26.2 RSR Major Business
9.26.3 RSR Aquaporin Product and Services
9.26.4 RSR Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 RSR Recent Developments/Updates
9.26.6 RSR Competitive Strengths & Weaknesses
9.27 Kronus
9.27.1 Kronus Details
9.27.2 Kronus Major Business
9.27.3 Kronus Aquaporin Product and Services
9.27.4 Kronus Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Kronus Recent Developments/Updates
9.27.6 Kronus Competitive Strengths & Weaknesses
9.28 Medical & Biological Laboratories
9.28.1 Medical & Biological Laboratories Details
9.28.2 Medical & Biological Laboratories Major Business
9.28.3 Medical & Biological Laboratories Aquaporin Product and Services
9.28.4 Medical & Biological Laboratories Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Medical & Biological Laboratories Recent Developments/Updates
9.28.6 Medical & Biological Laboratories Competitive Strengths & Weaknesses
9.29 ABclonal
9.29.1 ABclonal Details
9.29.2 ABclonal Major Business
9.29.3 ABclonal Aquaporin Product and Services
9.29.4 ABclonal Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 ABclonal Recent Developments/Updates
9.29.6 ABclonal Competitive Strengths & Weaknesses
9.30 Sino Biological
9.30.1 Sino Biological Details
9.30.2 Sino Biological Major Business
9.30.3 Sino Biological Aquaporin Product and Services
9.30.4 Sino Biological Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Sino Biological Recent Developments/Updates
9.30.6 Sino Biological Competitive Strengths & Weaknesses
9.31 Elabscience Biotechnology
9.31.1 Elabscience Biotechnology Details
9.31.2 Elabscience Biotechnology Major Business
9.31.3 Elabscience Biotechnology Aquaporin Product and Services
9.31.4 Elabscience Biotechnology Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Elabscience Biotechnology Recent Developments/Updates
9.31.6 Elabscience Biotechnology Competitive Strengths & Weaknesses
9.32 FineTest
9.32.1 FineTest Details
9.32.2 FineTest Major Business
9.32.3 FineTest Aquaporin Product and Services
9.32.4 FineTest Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 FineTest Recent Developments/Updates
9.32.6 FineTest Competitive Strengths & Weaknesses
9.33 HUABIO
9.33.1 HUABIO Details
9.33.2 HUABIO Major Business
9.33.3 HUABIO Aquaporin Product and Services
9.33.4 HUABIO Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 HUABIO Recent Developments/Updates
9.33.6 HUABIO Competitive Strengths & Weaknesses
9.34 CUSABIO
9.34.1 CUSABIO Details
9.34.2 CUSABIO Major Business
9.34.3 CUSABIO Aquaporin Product and Services
9.34.4 CUSABIO Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 CUSABIO Recent Developments/Updates
9.34.6 CUSABIO Competitive Strengths & Weaknesses
9.35 Cloud-Clone
9.35.1 Cloud-Clone Details
9.35.2 Cloud-Clone Major Business
9.35.3 Cloud-Clone Aquaporin Product and Services
9.35.4 Cloud-Clone Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Cloud-Clone Recent Developments/Updates
9.35.6 Cloud-Clone Competitive Strengths & Weaknesses
9.36 Abnova
9.36.1 Abnova Details
9.36.2 Abnova Major Business
9.36.3 Abnova Aquaporin Product and Services
9.36.4 Abnova Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Abnova Recent Developments/Updates
9.36.6 Abnova Competitive Strengths & Weaknesses
9.37 Boster Biological Technology
9.37.1 Boster Biological Technology Details
9.37.2 Boster Biological Technology Major Business
9.37.3 Boster Biological Technology Aquaporin Product and Services
9.37.4 Boster Biological Technology Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 Boster Biological Technology Recent Developments/Updates
9.37.6 Boster Biological Technology Competitive Strengths & Weaknesses
9.38 Affinity Biosciences
9.38.1 Affinity Biosciences Details
9.38.2 Affinity Biosciences Major Business
9.38.3 Affinity Biosciences Aquaporin Product and Services
9.38.4 Affinity Biosciences Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Affinity Biosciences Recent Developments/Updates
9.38.6 Affinity Biosciences Competitive Strengths & Weaknesses
9.39 Signalway Antibody
9.39.1 Signalway Antibody Details
9.39.2 Signalway Antibody Major Business
9.39.3 Signalway Antibody Aquaporin Product and Services
9.39.4 Signalway Antibody Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Signalway Antibody Recent Developments/Updates
9.39.6 Signalway Antibody Competitive Strengths & Weaknesses
9.40 ImmunoWay Biotechnology
9.40.1 ImmunoWay Biotechnology Details
9.40.2 ImmunoWay Biotechnology Major Business
9.40.3 ImmunoWay Biotechnology Aquaporin Product and Services
9.40.4 ImmunoWay Biotechnology Aquaporin Revenue, Gross Margin and Market Share (2021-2026)
9.40.5 ImmunoWay Biotechnology Recent Developments/Updates
9.40.6 ImmunoWay Biotechnology Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Aquaporin Industry Chain
10.2 Aquaporin Upstream Analysis
10.3 Aquaporin Midstream Analysis
10.4 Aquaporin Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer


LIST OF TABLES

Table 1. World Aquaporin Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Aquaporin Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Aquaporin Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Aquaporin Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Aquaporin Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Aquaporin Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Aquaporin Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Aquaporin Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Aquaporin Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Aquaporin Players in 2025
Table 12. World Aquaporin Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Aquaporin Company Evaluation Quadrant
Table 14. Head Office of Key Aquaporin Players
Table 15. Aquaporin Market: Company Product Type Footprint
Table 16. Aquaporin Market: Company Product Application Footprint
Table 17. Aquaporin Mergers & Acquisitions Activity
Table 18. United States VS China Aquaporin Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Aquaporin Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Aquaporin Companies, Headquarters (States, Country)
Table 21. United States Based Companies Aquaporin Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Aquaporin Revenue Market Share (2021-2026)
Table 23. China Based Aquaporin Companies, Headquarters (Province, Country)
Table 24. China Based Companies Aquaporin Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Aquaporin Revenue Market Share (2021-2026)
Table 26. Rest of World Based Aquaporin Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Aquaporin Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Aquaporin Revenue Market Share (2021-2026)
Table 29. World Aquaporin Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Aquaporin Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Aquaporin Market Size by Type (2027-2032) & (USD Million)
Table 32. World Aquaporin Market Size by Target Isoform, (USD Million), 2021 & 2025 & 2032
Table 33. World Aquaporin Market Size Value by Target Isoform (2021-2026) & (USD Million)
Table 34. World Aquaporin Market Size by Target Isoform (2027-2032) & (USD Million)
Table 35. World Aquaporin Market Size by Physical State, (USD Million), 2021 & 2025 & 2032
Table 36. World Aquaporin Market Size Value by Physical State (2021-2026) & (USD Million)
Table 37. World Aquaporin Market Size by Physical State (2027-2032) & (USD Million)
Table 38. World Aquaporin Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Aquaporin Market Size by Application (2021-2026) & (USD Million)
Table 40. World Aquaporin Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Aquaporin Product and Services
Table 44. Thermo Fisher Scientific Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher Aquaporin Product and Services
Table 50. Danaher Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Aquaporin Product and Services
Table 56. Merck KGaA Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. Merck KGaA Competitive Strengths & Weaknesses
Table 59. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Techne Major Business
Table 61. Bio-Techne Aquaporin Product and Services
Table 62. Bio-Techne Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Techne Recent Developments/Updates
Table 64. Bio-Techne Competitive Strengths & Weaknesses
Table 65. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Bio-Rad Laboratories Major Business
Table 67. Bio-Rad Laboratories Aquaporin Product and Services
Table 68. Bio-Rad Laboratories Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Bio-Rad Laboratories Recent Developments/Updates
Table 70. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 71. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 72. Cell Signaling Technology Major Business
Table 73. Cell Signaling Technology Aquaporin Product and Services
Table 74. Cell Signaling Technology Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cell Signaling Technology Recent Developments/Updates
Table 76. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 77. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 78. Proteintech Group Major Business
Table 79. Proteintech Group Aquaporin Product and Services
Table 80. Proteintech Group Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Proteintech Group Recent Developments/Updates
Table 82. Proteintech Group Competitive Strengths & Weaknesses
Table 83. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 84. Santa Cruz Biotechnology Major Business
Table 85. Santa Cruz Biotechnology Aquaporin Product and Services
Table 86. Santa Cruz Biotechnology Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Santa Cruz Biotechnology Recent Developments/Updates
Table 88. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 89. Alomone Labs Basic Information, Manufacturing Base and Competitors
Table 90. Alomone Labs Major Business
Table 91. Alomone Labs Aquaporin Product and Services
Table 92. Alomone Labs Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Alomone Labs Recent Developments/Updates
Table 94. Alomone Labs Competitive Strengths & Weaknesses
Table 95. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 96. Cayman Chemical Major Business
Table 97. Cayman Chemical Aquaporin Product and Services
Table 98. Cayman Chemical Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Cayman Chemical Recent Developments/Updates
Table 100. Cayman Chemical Competitive Strengths & Weaknesses
Table 101. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 102. MedChemExpress Major Business
Table 103. MedChemExpress Aquaporin Product and Services
Table 104. MedChemExpress Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. MedChemExpress Recent Developments/Updates
Table 106. MedChemExpress Competitive Strengths & Weaknesses
Table 107. TargetMol Basic Information, Manufacturing Base and Competitors
Table 108. TargetMol Major Business
Table 109. TargetMol Aquaporin Product and Services
Table 110. TargetMol Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. TargetMol Recent Developments/Updates
Table 112. TargetMol Competitive Strengths & Weaknesses
Table 113. Abbexa Basic Information, Manufacturing Base and Competitors
Table 114. Abbexa Major Business
Table 115. Abbexa Aquaporin Product and Services
Table 116. Abbexa Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Abbexa Recent Developments/Updates
Table 118. Abbexa Competitive Strengths & Weaknesses
Table 119. GeneTex Basic Information, Manufacturing Base and Competitors
Table 120. GeneTex Major Business
Table 121. GeneTex Aquaporin Product and Services
Table 122. GeneTex Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. GeneTex Recent Developments/Updates
Table 124. GeneTex Competitive Strengths & Weaknesses
Table 125. Atlas Antibodies Basic Information, Manufacturing Base and Competitors
Table 126. Atlas Antibodies Major Business
Table 127. Atlas Antibodies Aquaporin Product and Services
Table 128. Atlas Antibodies Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Atlas Antibodies Recent Developments/Updates
Table 130. Atlas Antibodies Competitive Strengths & Weaknesses
Table 131. StressMarq Biosciences Basic Information, Manufacturing Base and Competitors
Table 132. StressMarq Biosciences Major Business
Table 133. StressMarq Biosciences Aquaporin Product and Services
Table 134. StressMarq Biosciences Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. StressMarq Biosciences Recent Developments/Updates
Table 136. StressMarq Biosciences Competitive Strengths & Weaknesses
Table 137. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 138. Biorbyt Major Business
Table 139. Biorbyt Aquaporin Product and Services
Table 140. Biorbyt Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Biorbyt Recent Developments/Updates
Table 142. Biorbyt Competitive Strengths & Weaknesses
Table 143. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 144. NSJ Bioreagents Major Business
Table 145. NSJ Bioreagents Aquaporin Product and Services
Table 146. NSJ Bioreagents Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. NSJ Bioreagents Recent Developments/Updates
Table 148. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 149. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 150. Aviva Systems Biology Major Business
Table 151. Aviva Systems Biology Aquaporin Product and Services
Table 152. Aviva Systems Biology Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Aviva Systems Biology Recent Developments/Updates
Table 154. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 155. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 156. MyBioSource Major Business
Table 157. MyBioSource Aquaporin Product and Services
Table 158. MyBioSource Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. MyBioSource Recent Developments/Updates
Table 160. MyBioSource Competitive Strengths & Weaknesses
Table 161. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 162. Assay Genie Major Business
Table 163. Assay Genie Aquaporin Product and Services
Table 164. Assay Genie Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Assay Genie Recent Developments/Updates
Table 166. Assay Genie Competitive Strengths & Weaknesses
Table 167. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 168. RayBiotech Major Business
Table 169. RayBiotech Aquaporin Product and Services
Table 170. RayBiotech Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. RayBiotech Recent Developments/Updates
Table 172. RayBiotech Competitive Strengths & Weaknesses
Table 173. Bioss Antibodies Basic Information, Manufacturing Base and Competitors
Table 174. Bioss Antibodies Major Business
Table 175. Bioss Antibodies Aquaporin Product and Services
Table 176. Bioss Antibodies Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Bioss Antibodies Recent Developments/Updates
Table 178. Bioss Antibodies Competitive Strengths & Weaknesses
Table 179. OriGene Technologies Basic Information, Manufacturing Base and Competitors
Table 180. OriGene Technologies Major Business
Table 181. OriGene Technologies Aquaporin Product and Services
Table 182. OriGene Technologies Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. OriGene Technologies Recent Developments/Updates
Table 184. OriGene Technologies Competitive Strengths & Weaknesses
Table 185. Biomatik Basic Information, Manufacturing Base and Competitors
Table 186. Biomatik Major Business
Table 187. Biomatik Aquaporin Product and Services
Table 188. Biomatik Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Biomatik Recent Developments/Updates
Table 190. Biomatik Competitive Strengths & Weaknesses
Table 191. RSR Basic Information, Manufacturing Base and Competitors
Table 192. RSR Major Business
Table 193. RSR Aquaporin Product and Services
Table 194. RSR Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. RSR Recent Developments/Updates
Table 196. RSR Competitive Strengths & Weaknesses
Table 197. Kronus Basic Information, Manufacturing Base and Competitors
Table 198. Kronus Major Business
Table 199. Kronus Aquaporin Product and Services
Table 200. Kronus Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Kronus Recent Developments/Updates
Table 202. Kronus Competitive Strengths & Weaknesses
Table 203. Medical & Biological Laboratories Basic Information, Manufacturing Base and Competitors
Table 204. Medical & Biological Laboratories Major Business
Table 205. Medical & Biological Laboratories Aquaporin Product and Services
Table 206. Medical & Biological Laboratories Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Medical & Biological Laboratories Recent Developments/Updates
Table 208. Medical & Biological Laboratories Competitive Strengths & Weaknesses
Table 209. ABclonal Basic Information, Manufacturing Base and Competitors
Table 210. ABclonal Major Business
Table 211. ABclonal Aquaporin Product and Services
Table 212. ABclonal Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. ABclonal Recent Developments/Updates
Table 214. ABclonal Competitive Strengths & Weaknesses
Table 215. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 216. Sino Biological Major Business
Table 217. Sino Biological Aquaporin Product and Services
Table 218. Sino Biological Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Sino Biological Recent Developments/Updates
Table 220. Sino Biological Competitive Strengths & Weaknesses
Table 221. Elabscience Biotechnology Basic Information, Manufacturing Base and Competitors
Table 222. Elabscience Biotechnology Major Business
Table 223. Elabscience Biotechnology Aquaporin Product and Services
Table 224. Elabscience Biotechnology Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Elabscience Biotechnology Recent Developments/Updates
Table 226. Elabscience Biotechnology Competitive Strengths & Weaknesses
Table 227. FineTest Basic Information, Manufacturing Base and Competitors
Table 228. FineTest Major Business
Table 229. FineTest Aquaporin Product and Services
Table 230. FineTest Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. FineTest Recent Developments/Updates
Table 232. FineTest Competitive Strengths & Weaknesses
Table 233. HUABIO Basic Information, Manufacturing Base and Competitors
Table 234. HUABIO Major Business
Table 235. HUABIO Aquaporin Product and Services
Table 236. HUABIO Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. HUABIO Recent Developments/Updates
Table 238. HUABIO Competitive Strengths & Weaknesses
Table 239. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 240. CUSABIO Major Business
Table 241. CUSABIO Aquaporin Product and Services
Table 242. CUSABIO Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. CUSABIO Recent Developments/Updates
Table 244. CUSABIO Competitive Strengths & Weaknesses
Table 245. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 246. Cloud-Clone Major Business
Table 247. Cloud-Clone Aquaporin Product and Services
Table 248. Cloud-Clone Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Cloud-Clone Recent Developments/Updates
Table 250. Cloud-Clone Competitive Strengths & Weaknesses
Table 251. Abnova Basic Information, Manufacturing Base and Competitors
Table 252. Abnova Major Business
Table 253. Abnova Aquaporin Product and Services
Table 254. Abnova Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Abnova Recent Developments/Updates
Table 256. Abnova Competitive Strengths & Weaknesses
Table 257. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 258. Boster Biological Technology Major Business
Table 259. Boster Biological Technology Aquaporin Product and Services
Table 260. Boster Biological Technology Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. Boster Biological Technology Recent Developments/Updates
Table 262. Boster Biological Technology Competitive Strengths & Weaknesses
Table 263. Affinity Biosciences Basic Information, Manufacturing Base and Competitors
Table 264. Affinity Biosciences Major Business
Table 265. Affinity Biosciences Aquaporin Product and Services
Table 266. Affinity Biosciences Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Affinity Biosciences Recent Developments/Updates
Table 268. Affinity Biosciences Competitive Strengths & Weaknesses
Table 269. Signalway Antibody Basic Information, Manufacturing Base and Competitors
Table 270. Signalway Antibody Major Business
Table 271. Signalway Antibody Aquaporin Product and Services
Table 272. Signalway Antibody Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Signalway Antibody Recent Developments/Updates
Table 274. Signalway Antibody Competitive Strengths & Weaknesses
Table 275. ImmunoWay Biotechnology Basic Information, Manufacturing Base and Competitors
Table 276. ImmunoWay Biotechnology Major Business
Table 277. ImmunoWay Biotechnology Aquaporin Product and Services
Table 278. ImmunoWay Biotechnology Aquaporin Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 279. ImmunoWay Biotechnology Recent Developments/Updates
Table 280. ImmunoWay Biotechnology Competitive Strengths & Weaknesses
Table 281. Global Key Players of Aquaporin Upstream (Raw Materials)
Table 282. Global Aquaporin Typical Customers

LIST OF FIGURES

Figure 1. Aquaporin Picture
Figure 2. World Aquaporin Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Aquaporin Total Revenue (2021-2032) & (USD Million)
Figure 4. World Aquaporin Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Aquaporin Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Aquaporin Revenue (2021-2032) & (USD Million)
Figure 13. Aquaporin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 16. World Aquaporin Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 18. China Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 23. India Aquaporin Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Aquaporin by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Aquaporin Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Aquaporin Markets in 2025
Figure 27. United States VS China: Aquaporin Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Aquaporin Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Aquaporin Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Aquaporin Market Size Market Share by Type in 2025
Figure 31. Anti-Aquaporin Antibody
Figure 32. Aquaporin Channel Blocker
Figure 33. Others
Figure 34. World Aquaporin Market Size Market Share by Type (2021-2032)
Figure 35. World Aquaporin Market Size by Target Isoform, (USD Million), 2021 & 2025 & 2032
Figure 36. World Aquaporin Market Size Market Share by Target Isoform in 2025
Figure 37. AQP1 Products
Figure 38. AQP2 Products
Figure 39. AQP3 Products
Figure 40. AQP4 Products
Figure 41. Others
Figure 42. World Aquaporin Market Size Market Share by Target Isoform (2021-2032)
Figure 43. World Aquaporin Market Size by Physical State, (USD Million), 2021 & 2025 & 2032
Figure 44. World Aquaporin Market Size Market Share by Physical State in 2025
Figure 45. Solid Products
Figure 46. Liquid Products
Figure 47. World Aquaporin Market Size Market Share by Physical State (2021-2032)
Figure 48. World Aquaporin Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Aquaporin Market Size Market Share by Application in 2025
Figure 50. Medicine
Figure 51. Research
Figure 52. Purification Of Water
Figure 53. Others
Figure 54. World Aquaporin Market Size Market Share by Application (2021-2032)
Figure 55. Aquaporin Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source


More Publications